📊 CVAT Key Takeaways
Is Cavitation Technologies, Inc. (CVAT) a Good Investment?
Cavitation Technologies exhibits terminal financial distress with revenue collapsing 85% YoY to $3K, negative stockholders' equity of -$248K, and chronic operating losses of -$723K. The company burns cash at an unsustainable rate (-$401K operating cash flow) while holding minimal liquid assets ($31K) against $303K in liabilities, indicating imminent solvency risk.
Cavitation Technologies shows extremely weak fundamentals: revenue has collapsed to a negligible level, losses vastly exceed sales, and operating cash flow remains deeply negative. The balance sheet is distressed, with negative equity, weak liquidity, and liabilities far exceeding assets, which raises serious going-concern and financing risk. Growth quality is poor because the business is not demonstrating scalable revenue or any path to sustainable profitability.
Why Buy Cavitation Technologies, Inc. Stock? CVAT Key Strengths
- Maintains positive gross margin at 100% on minimal revenue base
- Retains $31K in cash reserves providing short-term liquidity buffer
- Agricultural services sector has long-term demand fundamentals
- Positive gross profit on the latest period, indicating no immediate gross-level loss on reported revenue
- Asset-light profile with no capital expenditure burden in the latest period
- Some cash remains on hand, providing limited near-term operating flexibility
CVAT Stock Risks: Cavitation Technologies, Inc. Investment Risks
- Negative stockholders' equity of -$248K indicates technical insolvency
- Revenue near zero ($3K) with 85% YoY decline suggests business model failure
- Operating cash burn of -$401K annually unsustainable given $31K cash position
- Current ratio of 0.29x and quick ratio of 0.22x indicate critical liquidity crisis
- $150K long-term debt obligations exceed total assets of $55K
- Negative operating and net margins exceeding -24,000% reflect structural unprofitability
- Revenue declined 85.1% year over year to an immaterial level, indicating severe business deterioration
- Negative stockholders' equity and a current ratio of 0.29x point to substantial financial distress
- Operating cash burn and net losses are far too large relative to revenue, with no evidence of sustainable profitability
Key Metrics to Watch
- Cash position depletion rate and months of runway remaining
- Revenue stabilization or further deterioration trajectory
- Debt covenant compliance status and refinancing needs
- Operating cash flow trend and path to breakeven
- Quarterly revenue recovery and consistency of commercial sales
- Operating cash flow and ending cash balance
Cavitation Technologies, Inc. (CVAT) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
CVAT Profit Margin, ROE & Profitability Analysis
CVAT vs Services Sector: How Cavitation Technologies, Inc. Compares
How Cavitation Technologies, Inc. compares to Services sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Cavitation Technologies, Inc. Stock Overvalued? CVAT Valuation Analysis 2026
Based on fundamental analysis, Cavitation Technologies, Inc. has mixed fundamental signals relative to the Services sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Cavitation Technologies, Inc. Balance Sheet: CVAT Debt, Cash & Liquidity
CVAT Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Cavitation Technologies, Inc.'s revenue has declined by 47% over the 5-year period, indicating business contraction. The most recent EPS of $0.00 indicates the company is currently unprofitable.
CVAT Revenue Growth, EPS Growth & YoY Performance
CVAT Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 2026 | N/A | $352.0K | $0.00 |
| Q1 2026 | N/A | -$227.0K | $0.00 |
| Q3 2025 | $122.0K | $64.0K | $0.00 |
| Q2 2025 | $76.0K | -$16.0K | $0.00 |
| Q1 2025 | N/A | -$227.0K | $0.00 |
| Q3 2024 | $61.0K | $64.0K | $0.00 |
| Q2 2024 | $58.0K | -$16.0K | $0.00 |
| Q1 2024 | N/A | -$73.0K | $0.00 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Cavitation Technologies, Inc. Dividends, Buybacks & Capital Allocation
CVAT SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Cavitation Technologies, Inc. (CIK: 0001376793)
📋 Recent SEC Filings
❓ Frequently Asked Questions about CVAT
What is the AI rating for CVAT?
Cavitation Technologies, Inc. (CVAT) has a Combined AI Rating of STRONG SELL from Claude (STRONG SELL) and ChatGPT (STRONG SELL) with 96% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are CVAT's key strengths?
Claude: Maintains positive gross margin at 100% on minimal revenue base. Retains $31K in cash reserves providing short-term liquidity buffer. ChatGPT: Positive gross profit on the latest period, indicating no immediate gross-level loss on reported revenue. Asset-light profile with no capital expenditure burden in the latest period.
What are the risks of investing in CVAT?
Claude: Negative stockholders' equity of -$248K indicates technical insolvency. Revenue near zero ($3K) with 85% YoY decline suggests business model failure. ChatGPT: Revenue declined 85.1% year over year to an immaterial level, indicating severe business deterioration. Negative stockholders' equity and a current ratio of 0.29x point to substantial financial distress.
What is CVAT's revenue and growth?
Cavitation Technologies, Inc. reported revenue of $3.0K.
Does CVAT pay dividends?
Cavitation Technologies, Inc. does not currently pay dividends.
Where can I find CVAT SEC filings?
Official SEC filings for Cavitation Technologies, Inc. (CIK: 0001376793) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is CVAT's EPS?
Cavitation Technologies, Inc. has a diluted EPS of $0.00.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is CVAT a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Cavitation Technologies, Inc. has a STRONG SELL rating with 96% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is CVAT stock overvalued or undervalued?
Valuation metrics for CVAT: ROE of N/A (sector avg: 16%), net margin of -24,466.7% (sector avg: 10%). Compare these metrics with sector averages to assess valuation.
Should I buy CVAT stock in 2026?
Our dual AI analysis gives Cavitation Technologies, Inc. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is CVAT's free cash flow?
Cavitation Technologies, Inc.'s operating cash flow is $-401.0K, with capital expenditures of $0.0. FCF margin is -13,366.7%.
How does CVAT compare to other Services stocks?
Vs Services sector averages: Net margin -24,466.7% (avg: 10%), ROE N/A (avg: 16%), current ratio 0.29 (avg: 1.5).